WIRB-Copernicus Group Launches Non-Profit Foundation
WIRB-Copernicus Group® (WCG™), a provider of regulatory and ethical review services and software to support clinical research, announced the launch of WCG Foundation to strengthen protections for research participants and improve health and well-being worldwide.
WCG Foundation will initially focus on three programs: advancing education and training in research ethics at U.S. academic institutions, providing scholarships for the Western Institutional Review Board® (WIRB) International Fellows Program, and making IRB review more affordable for patients who are desperate to gain access to experimental treatments.
Read the full release.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ifinatamab Deruxtecan Shows High Response Rates for Heavily Pretreated Small Cell Lung Cancer
September 9th 2024Potential first-in-class B7-H3 directed antibody drug conjugate ifinatamab deruxtecan shows potential to improve outcomes for patients living with difficult-to-treat form of lung cancer.
